Table Of Content 1INTRODUCTION 1.1. OVERVIEW OF THE EAR AND NASAL PACKING MARKET 1.2. MARKET SEGMENTATION & COVERAGE 1.2.1. CURRENCY AND PRICING 1.2.2. LIMITATION 1.2.3. STAKEHOLDERS 2. RESEARCH METHODOLOGY 2.1. KEY TAKEAWAYS 2.2. ARRIVING AT THE EAR AND NASAL PACKING SIZE 2.2.1. MARKET CRACKDOWN APPROACH 2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS 2.2.3. DATA TRIANGULATION 2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES 2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES 2.2.6. PORTER’S FIVE FORCES MATRIX 2.3. GLOBAL EAR AND NASAL PACKING MARKET: RESEARCH SNAPSHOT 2.4. ASSUMPTIONS 3. MARKET LANDSCAPE SUMMARY 4. PREMIUM INSIGHTS 4.1. OVERVIEW 4.2. GLOBAL EAR AND NASAL PACKING MARKET: KEY PRIMARY INSIGHTS 4.3. MARKET OVERVIEW 4.3.1. DRIVERS 4.3.1.1. HIGH PREVALENCE OF CHRONIC SINUSITIS 4.3.1.2. GROWING ADOPTION OF MINIMALLY INVASIVE PROCEDURES 4.3.1.3. TECHNOLOGICAL DEVELOPEMENTS 4.3.1.4. FAVOURABLE REIMBURSEMENTS 4.3.2. RESTRAINTS 4.3.3. OPPURTUNITIES 4.3.4. THREATS 4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES 5. EXECUTIVE SUMMARY 6. EAR AND NASAL PACKING MARKET, BY TYPE 6.1. OVERVIEW 6.2. NASAL PACKING, BY PRODUCT TYPE (2014 – 2022) 6.2.1. INJECTABLE 6.2.2. GEL 6.2.3. DRESSINGS, BY PRODUCT TYPE 6.2.3.1. SPONGES 6.2.3.2. SPLINTS 6.2.3.3. STRIPS 6.2.3.4. OTHERS 6.3. EAR PACKING, BY PRODUCT TYPE (2014 – 2022) 6.3.1. INJECTABLE 6.3.2. GEL 6.3.3. DRESSINGS, BY PRODUCT TYPE 6.3.3.1. SPONGES 6.3.3.2. SPLINTS 6.3.3.3. STRIPS 7. EAR AND NASAL PACKING MARKET, BY MATERIAL 7.1. OVERVIEW 7.2. BIORESORBABLE, BY MATERIAL 7.2.1. CHITOSAN 7.2.2. HYAFF (HYALURONIC ACID) 7.2.3. COMBINATION 7.3. NON-ABSORBABLE 7.3.1. CMC (CARBOXYMETHYL CELLULOSE) 7.3.2. SYNTHETIC 7.3.3. OTHERS 8. EAR AND NASAL PACKING MARKET, BY END USER 8.1. OVERVIEW 8.2. HOSPITAL 8.3. CLINICS 8.4. AMBULATORY CENTERS 8.5. OTHERS 9. EAR AND NASAL PACKING MARKET, BY DISTRIBUTION CHANNEL 9.1. OVERVIEW 9.2. DIRECT TENDER 9.3. OVER THE COUNTER 10. EAR AND NASAL PACKING MARKET, BY GEOGRAPHY 10.1. COUNTRYWISE EAR AND NASAL PACKING MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY) 10.1.1. NORTH AMERICA 10.1.1.1. U.S. 10.1.1.2. CANADA 10.1.1.3. MEXICO 10.1.2. EUROPE 10.1.2.1. GERMANY 10.1.2.2. FRANCE 10.1.2.3. U.K. 10.1.2.4. ITALY 10.1.2.5. SPAIN 10.1.2.6. RUSSIA 10.1.2.7. TURKEY 10.1.2.8. BELGIUM 10.1.2.9. NETHERLANDS 10.1.2.10. SWITZERLAND 10.1.2.11. REST OF EUROPE 10.1.3. ASIA-PACIFIC (APAC) 10.1.3.1. JAPAN 10.1.3.2. CHINA 10.1.3.3. SOUTH KOREA 10.1.3.4. INDIA 10.1.3.5. AUSTRALIA 10.1.3.6. SINGAPORE 10.1.3.7. THAILAND 10.1.3.8. MALAYSIA 10.1.3.9. INDONESIA 10.1.3.10. PHILIPPINES 10.1.3.11. REST OF APAC 10.1.4. SOUTH AMERICA 10.1.4.1. BRAZIL 10.1.4.2. REST OF LATIN AMERICA 10.1.5. MIDDLE EAST AND AFRICA 10.1.5.1. SOUTH AFRICA 10.1.5.2. REST OF MIDDLE EAST AND AFRICA 10.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES 11. EAR AND NASAL PACKING MARKET: COMPETITIVE LANDSCAPE 11.1. GLOBAL EAR AND NASAL PACKING MARKET: COMPANY SHARE ANALYSIS 11.2. U.S. EAR AND NASAL PACKING MARKET: COMPANY SHARE ANALYSIS 11.3. MERGERS & ACQUISITIONS 11.4. NEW PRODUCT DEVELOPMENT & APPROVALS 11.5. EXPANSIONS 11.6. REGULATORY CHANGES 11.7. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS 12. EAR AND NASAL PACKING MARKET, COMPANY PROFILES 12.1. MEDTRONIC 12.1.1. OVERVIEW 12.1.2. SWOT ANALYSIS 12.1.3. PRODUCT PORTFOLIO 12.1.4. REVENUE ANALYSIS 12.1.5. ANALYSTS VIEW 12.2. STRYKER 12.2.1. OVERVIEW 12.2.2. SWOT ANALYSIS 12.2.3. PRODUCT PORTFOLIO 12.2.4. REVENUE ANALYSIS 12.2.5. ANALYSTS VIEW 12.3. SUMMIT MEDICAL 12.3.1. OVERVIEW 12.3.2. SWOT ANALYSIS 12.3.3. PRODUCT PORTFOLIO 12.3.4. REVENUE ANALYSIS 12.3.5. ANALYST VIEW 12.4. SMITH AND NEPHEW 12.4.1. OVERVIEW 12.4.2. SWOT ANALYSIS 12.4.3. PRODUCT PORTFOLIO 12.4.4. REVENUE ANALYSIS 12.4.5. ANALYSTS VIEW 12.5. ENTELLUS MEDICAL, INC. 12.5.1. OVERVIEW 12.5.2. SWOT ANALYSIS 12.5.3. PRODUCT PORTFOLIO 12.5.4. REVENUE ANALYSIS 12.5.5. ANALYSTS VIEW 12.6. OLYMPUS MEDICAL 12.6.1. OVERVIEW 12.6.2. SWOT ANALYSIS 12.6.3. PRODUCT PORTFOLIO 12.6.4. REVENUE ANALYSIS 12.6.5. ANALYSTS VIEW 12.7. BOSTON MEDICAL PRODUCTS, INC. 12.7.1. OVERVIEW 12.7.2. SWOT ANALYSIS 12.7.3. PRODUCT PORTFOLIO 12.7.4. REVENUE ANALYSIS 12.7.5. ANALYSTS VIEW 12.8. LOHMANN & RAUSCHER 12.8.1. OVERVIEW 12.8.2. SWOT ANALYSIS 12.8.3. PRODUCT PORTFOLIO 12.8.4. REVENUE ANALYSIS 12.1.5. ANALYSTS VIEW 12.9. NETWORK MEDICAL PRODUCTS LTD. 12.9.1. OVERVIEW 12.9.2. SWOT ANALYSIS 12.9.3. PRODUCT PORTFOLIO 12.9.4. REVENUE ANALYSIS 12.9.5. ANALYSTS VIEW 12.10. FANNIN 12.10.1. OVERVIEW 12.10.2. SWOT ANALYSIS 12.10.3. PRODUCT PORTFOLIO 12.10.4. REVENUE ANALYSIS 12.10.5. ANALYSTS VIEW 13. APPENDIX 14. ABOUT DATA BRIDGE MARKET RESEARCH

• Stryker and Smith • Nephew • Summit Medical Group, • Entellus Medical, Inc., • Olympus Corporation, • Network Medical Products Ltd., • Lohmann & Rauscher GmbH & Co. KG • DCC plc